Ibstock PLC Reports Resilient FY25 Performance with Revenue Growth and Robust Balance Sheet

Ibstock is also advancing a calcined clay opportunity, with a preferred partner and commercial terms expected in H1 2026. Calcined clay can help reduce clinker content in cement-related applications, supporting lower-carbon products – potentially a useful growth and ESG lever if the economics stack up. Details are not disclosed yet.

On the flip side, the Group has exited smaller, non-core areas. Surplus land assets and the Forticrete roofing sites were sold in Q4. Management says roofing was relatively small and its disposal will not meaningfully impact future financial performance. This is tidy portfolio work that boosts liquidity without cutting muscle.

Cost actions and capacity: short-term pain for long-term gain

Ibstock has reduced headcount and right-sized capacity to fit today’s demand, but crucially maintains ample headroom for a recovery. In H1 2026, it plans to actively manage production volumes and inventory. Translation: produce less to keep stock lean, which supports cash but creates a margin headwind in 2026.

This is credible capital discipline. In a slow market, cash is king. Sacrificing some near-term margin to protect cash and pricing is a rational trade-off, particularly with a strong asset base coming online.

Balance sheet and cash: optionality is the message

Net debt sits at around £120 million, broadly flat year-on-year and helped by about £30 million of disposal proceeds. Cash generation was in line with guidance, and leverage is moving in the right direction. The theme of the update is “optionality”: keep the balance sheet robust to fund growth at the right time and, potentially, capital returns.

Dividend or buyback specifics are not disclosed. The Board flags improved cash generation and lower leverage as enablers for future growth and returns, but stops short of commitments. That’s sensible given the macro uncertainty.

Outlook for 2026: cautious near-term, modest H2 uplift expected

• Residential and RMI (repair, maintenance and improvement) markets are expected to remain subdued near-term.
• Modest year-on-year volume growth is anticipated in H2 as markets recover.
• Pricing actions are expected to offset cost inflation – a positive for margin resilience.
• H1 production and inventory management will weigh on 2026 margins but support overall cash generation.
• Improved cash and reduced leverage provide optionality for future growth and capital returns.
• Board remains confident in medium-term prospects, though the pace and timing of recovery are uncertain.

Net-net, it’s a steady set-up: defend margins and cash in the lull, prepare for operating leverage when volumes return.

My take: sensible execution, poised for the turn

Positives:

• Revenue growth in a weak market, with stable pricing and share gains in Clay.
• Atlas and Nostell investments largely complete, offering efficiency and sustainability benefits into the next cycle.
• Balance sheet strengthened by c.£30 million of disposals; net debt around £120 million.
• Clear cash discipline and portfolio focus – cutting smaller, non-core activities without harming the core.

Watch-outs:

• Demand still well below 2022 levels; recovery timing remains uncertain.
• 2026 margin headwind due to production and inventory decisions in H1.
• EBITDA and cash flow numbers are not disclosed – we only know they’re “in line with guidance”.

Overall, this reads as a resilient performance with credible capital allocation. If volumes improve in H2 2026, the combination of modernised capacity and pricing discipline could drive attractive cash generation. Until then, expect sensible, cash-first choices.

What I’ll watch at the 5 March results

• Actual EBITDA and cash conversion versus the “in line with guidance” flag.
• Update on Atlas and Nostell ramp-up timelines and any capex tail.
• Details on calcined clay – partner, commercial terms, and expected returns.
• Inventory levels and production cadence into H1, given the planned cash-first approach.
• Any commentary on capital returns – currently not disclosed.

Ibstock has kept its powder dry and its plants ready. In tough markets, that’s the right playbook.